Title Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air® /
Authors Bousquet, Jean ; Sousa-Pinto, Bernardo ; Anto, Josep M ; Bedbrook, Anna ; Czarlewski, Wienczyslawa ; Ansotegui, Ignacio J ; Bergmann, Karl-C ; Braido, Fulvio ; Brussino, Luisa ; Cecchi, Lorenzo ; Loureiro, Claudia Chaves ; Cruz, Alvaro A ; Devillier, Philippe ; Fiocchi, Alessandro ; Gemicioglu, Bilun ; Haahtela, Tari ; Ivancevich, Juan Carlos ; Klimek, Ludger ; Kulus, Marek ; Kuna, Piotr ; Kupczyk, Maciej ; Kvedarienė, Violeta ; Larenas-Linnemann, Desiree E ; Louis, Gilles ; Louis, Renaud ; Makris, Michael ; Morais-Almeida, Mario ; Niedoszytko, Marek ; Ohta, Ken ; Ollert, Markus ; Papadopoulos, Nikolaos ; Patella, Vincenzo ; Pétré, Benoit ; Pfaar, Oliver ; Puggioni, Francesca ; Quirce, Santiago ; Regateiro, Frederico S ; Roche, Nicolas ; Rouadi, Philip W ; Samolinski, Boleslaw ; Sastre, Joaquin ; Schleich, Florence ; Scichilone, Nicola ; Taborda-Barata, Luis ; Toppila-Salmi, Sanna ; Valiulis, Arūnas ; Vardaloglu Koyuncu, Ilgim ; Ventura, Maria Teresa ; Yorgancioglu, Arzu ; Fonseca, Joao A ; Zuberbier, Torsten
DOI 10.1002/clt2.12390
Full Text Download
Is Part of Clinical and translational allergy.. Hoboken : Wiley. 2024, vol. 14, iss. 9, art. no. e12390, p. [1-17].. eISSN 2045-7022
Keywords [eng] asthma ; digital health ; EQ-5D ; rhinitis ; visual analogue scale
Abstract [eng] Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.
Published Hoboken : Wiley
Type Journal article
Language English
Publication date 2024
CC license CC license description